# 76Bio, Inc. — Form D/A

76Bio, Inc. of Boston, MA, a company, filed a Form D amendment with the SEC on 2023-02-14. The offering totals $12.2M, of which $12.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-02-14
- Form: D/A
- Accession: 0001437749-23-003303
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.2M
- Amount sold: $12.2M
- Investors: 32
- Date of first sale: 2023-02-06
- Revenue range: Decline to Disclose
- SEC file number: 021-473359

## Issuer

- Name: 76Bio, Inc.
- CIK: 0001903465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 40 Guest Street, Boston, MA, 01235
- Phone: 212-871-7920

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Angela M Koehler | Director | Boston, MA |
| David M Tanen | Director | New York, NY |
| Christopher M Wilfong | Director | Boston, MA |
| Christopher M Wilfong | Executive Officer | Boston, MA |
| David M Tanen | Promoter | New York, NY |
| Christopher M Wilfong | Promoter | Boston, MA |
| David M Tanen | Executive Officer | New York, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-02-13](https://search.stillhousedata.com/formd/0001437749-23-003187) | D | $12.2M | $12.2M |
| [2022-01-10](https://search.stillhousedata.com/formd/0001437749-22-000656) | D | $10.0M | $10.0M |

## More

- [CIK 1903465 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1903465&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001437749-23-003303.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.